National Historical Cash Flow
| NHI Stock | USD 68.83 0.54 0.78% |
Analysis of National Health cash flow over time is an excellent tool to project National Health Investors future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 73.5 M or Capital Expenditures of 3.6 M as it is a great indicator of National Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining National Health Investors latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether National Health Investors is a good buy for the upcoming year.
National |
About National Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in National balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which National's non-liquid assets can be easily converted into cash.
National Health Cash Flow Chart
Add Fundamental
Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Most accounts from National Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. As of now, National Health's Depreciation is increasing as compared to previous years. The National Health's current End Period Cash Flow is estimated to increase to about 30.8 M, while Other Cashflows From Financing Activities is forecasted to increase to (1 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Begin Period Cash Flow | 46.3M | 39.5M | 21.5M | 30.8M | End Period Cash Flow | 39.5M | 21.5M | 24.6M | 30.8M |
National Health cash flow statement Correlations
Click cells to compare fundamentals
National Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
National Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 5.8M | 30.7M | (6.9M) | (18.0M) | 3.1M | 3.3M | |
| Free Cash Flow | 241.0M | 232.1M | 210.8M | 185.3M | 180.7M | 189.7M | |
| Change In Working Capital | 18.7M | (6.7M) | (438K) | (2.7M) | 3.3M | 3.5M | |
| Other Cashflows From Financing Activities | 214.9M | (8.1M) | (7.4M) | 230.9M | (1.1M) | (1.0M) | |
| Depreciation | 76.8M | 83.2M | 80.8M | 70.9M | 70.0M | 73.5M | |
| Other Non Cash Items | (19.5M) | (18.4M) | 39.2M | 43.0M | (27.8M) | (26.4M) | |
| Capital Expenditures | 237.2M | 102.9M | 64K | 6.4M | 3.7M | 3.6M | |
| Total Cash From Operating Activities | 241.0M | 232.1M | 210.9M | 185.3M | 184.5M | 113.1M | |
| Net Income | 160.4M | 185.3M | 112.0M | 65.5M | 134.4M | 87.6M | |
| Total Cash From Financing Activities | 107.3M | (111.8M) | (403.0M) | (401.3M) | (169.7M) | (161.2M) | |
| End Period Cash Flow | 15.7M | 46.3M | 39.5M | 21.5M | 24.6M | 30.8M | |
| Begin Period Cash Flow | 9.9M | 15.7M | 46.3M | 39.5M | 21.5M | 30.8M | |
| Dividends Paid | 179.7M | 194.6M | 182.9M | 161.8M | 156.2M | 95.5M | |
| Sale Purchase Of Stock | (1.8M) | 95.8M | 100M | 491.8M | (152.0M) | 0.0 | |
| Total Cashflows From Investing Activities | (342.5M) | (89.7M) | 185.3M | 197.9M | 178.2M | 187.1M | |
| Change To Liabilities | 17.1M | (6.9M) | 3.6M | 837K | 753.3K | 715.6K | |
| Stock Based Compensation | 3.6M | 3.1M | 8.4M | 8.6M | 4.6M | 3.4M | |
| Investments | (342.5M) | (12.6M) | 1.2M | 40.0M | (11.6M) | (12.2M) | |
| Net Borrowings | 192.3M | 51.6M | (260.6M) | (98M) | (88.2M) | (83.8M) | |
| Other Cashflows From Investing Activities | (123.3M) | 25.8M | 235.4M | 164.3M | (7.9M) | (7.5M) | |
| Change To Netincome | (21.0M) | (35.5M) | 13.2M | (7.8M) | (7.0M) | (7.4M) | |
| Change To Operating Activities | 1.6M | 160K | (4.1M) | (3.5M) | (3.2M) | (3.0M) |
Currently Active Assets on Macroaxis
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 2.91 | Revenue Per Share 7.598 | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.